journal article·2026-07-21

An Injectable Magneto‐Responsive Periosteum Reprograms Neutrophil Extracellular Trap Formation for Osteomyelitis Treatment

Yifan Wu, Zhang Lin, Jinfeng Zhou, Congying Shen, Yuhan Fu, Kelei Wang, Shufeng Shen, Peipei Su, Xingzi He, Xiaoxiao Ji, Wei Wang, Yiying Qi, Gang Feng

Publisher page

Abstract

ABSTRACT Osteomyelitis caused by methicillin‐resistant Staphylococcus aureus (MRSA) biofilms presents significant therapeutic challenges due to antibiotic resistance and persistent bacterial presence. Inspired by the natural periosteum structure, we developed an injectable biomimetic periosteum through thiol‐click chemistry—a hydrogel loaded with NiSr MOF@Mem nanocomposites(NiSr MOF@Mem Gel). This system not only serves as a physical barrier covering bone defects but also, under alternating magnetic field (MF) activation, synergistically executes chemodynamic therapy, controlled antibiotic release, and immunomodulation. In vitro studies demonstrated that this biomimetic periosteum activates NADPH oxidase‐dependent ROS bursts under MF, driving PAD4‐mediated histone H3 citrullination and thereby inducing neutrophil extracellular trap (NET) formation. This process relies on the classical ROS/PAD4 signaling axis, as confirmed by the PAD4 inhibitor Cl‐Amidine significantly suppressing NETosis. Functional assays verified that the system, via NET induction, exerts potent synergistic antibacterial effects against both planktonic and biofilm‐embedded MRSA. In a rat osteomyelitis model, the biomimetic periosteum combined with MF treatment significantly reduced bacterial load in bone tissue and effectively promoted bone repair by modulating the immune microenvironment. This study presents a novel strategy of using a magnetically responsive biomimetic periosteum to remotely regulate innate immunity for biofilm eradication, offering an integrated solution for the synergistic treatment of osteomyelitis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neutrophil, Myeloperoxidase and Oxidative Mechanisms · Orthopedic Infections and Treatments · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang P. R. China

Orthopedics Research Institute of Zhejiang University Hangzhou Zhejiang P. R. China

Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province Hangzhou Zhejiang P. R. China

Clinical Research Center of Motor System Disease of Zhejiang Province Hangzhou Zhejiang P. R. China

College of Chemical and Biological Engineering Zhejiang University Hangzhou P. R. China

ZJU‐Hangzhou Global Scientific and Technological Innovation Center Hangzhou Hangzhou Zhejiang P. R. China

Department of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine Zhejiang University Hangzhou P. R. China

Department of Orthopedics Yangming Hospital Affiliated to Ningbo University Yuyao Zhejiang P. R. China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province · National Key Research and Development Program of China

References (46)

Show source-provided references
1. 10.1016/j.mtbio.2022.10028510.1016/j.mtbio.2022.100285 ↗
2. 10.1002/adma.20210017610.1002/adma.202100176 ↗
3. 10.1002/advs.20241236010.1002/advs.202412360 ↗
4. 10.1002/adma.20220204410.1002/adma.202202044 ↗
5. 10.1002/advs.20230558010.1002/advs.202305580 ↗
6. 10.1038/s41574‐024‐01039‐y10.1038/s41574‐024‐01039‐y ↗
7. 10.1038/s41586‐024‐07822‐110.1038/s41586‐024‐07822‐1 ↗
8. 10.1038/s41467‐024‐54817‐710.1038/s41467‐024‐54817‐7 ↗
9. 10.1126/sciimmunol.aar667610.1126/sciimmunol.aar6676 ↗
10. 10.1016/j.phrs.2024.10736310.1016/j.phrs.2024.107363 ↗
11. 10.1002/adma.20221029610.1002/adma.202210296 ↗
12. 10.1021/acsnano.3c0513010.1021/acsnano.3c05130 ↗
13. 10.1002/adma.20241443710.1002/adma.202414437 ↗
14. 10.1002/advs.20230696410.1002/advs.202306964 ↗
15. 10.1186/s12951‐021‐00936‐y10.1186/s12951‐021‐00936‐y ↗
16. 10.1002/advs.20220217310.1002/advs.202202173 ↗
17. 10.1002/adhm.20210197110.1002/adhm.202101971 ↗
18. 10.1016/j.ijbiomac.2018.08.12610.1016/j.ijbiomac.2018.08.126 ↗
19. 10.1002/cbic.20200009510.1002/cbic.202000095 ↗
20. 10.1016/j.cis.2023.10300710.1016/j.cis.2023.103007 ↗
21. 10.1016/j.actbio.2019.01.00510.1016/j.actbio.2019.01.005 ↗
22. 10.1016/j.jconrel.2019.07.03610.1016/j.jconrel.2019.07.036 ↗
23. 10.1021/acsnano.7b0872510.1021/acsnano.7b08725 ↗
24. 10.1021/acsnano.7b0446110.1021/acsnano.7b04461 ↗
25. 10.1016/j.jconrel.2017.05.01110.1016/j.jconrel.2017.05.011 ↗
26. 10.1016/j.actbio.2018.05.02610.1016/j.actbio.2018.05.026 ↗
27. 10.1039/d0ra09164b10.1039/d0ra09164b ↗
28. 10.1021/acsnano.6b0004310.1021/acsnano.6b00043 ↗
29. 10.1016/j.biomaterials.2017.03.04110.1016/j.biomaterials.2017.03.041 ↗
30. 10.1016/j.bioactmat.2023.01.02210.1016/j.bioactmat.2023.01.022 ↗
31. 10.1088/1758‐5090/aceaaf10.1088/1758‐5090/aceaaf ↗
32. 10.1021/acsmacrolett.3c0048210.1021/acsmacrolett.3c00482 ↗
33. 10.1016/j.actbio.2023.10.02310.1016/j.actbio.2023.10.023 ↗
34. 10.1016/j.jconrel.2020.12.03710.1016/j.jconrel.2020.12.037 ↗
35. 10.1016/j.addr.2019.04.00710.1016/j.addr.2019.04.007 ↗
36. 10.1039/c9ra09021e10.1039/c9ra09021e ↗
37. 10.1021/acsnano.3c0437810.1021/acsnano.3c04378 ↗
38. 10.1002/smll.20220214510.1002/smll.202202145 ↗
39. 10.1002/smll.20220340010.1002/smll.202203400 ↗
40. 10.1016/j.redox.2023.10290610.1016/j.redox.2023.102906 ↗
41. 10.1126/science.109238510.1126/science.1092385 ↗
42. 10.1126/scitranslmed.adh509010.1126/scitranslmed.adh5090 ↗
43. 10.1016/j.biomaterials.2022.12166310.1016/j.biomaterials.2022.121663 ↗
44. 10.1002/advs.20230796910.1002/advs.202307969 ↗
45. 10.1016/j.jconrel.2024.10.02110.1016/j.jconrel.2024.10.021 ↗
46. 10.1007/s10534‐017‐0002‐510.1007/s10534‐017‐0002‐5 ↗